About 100 reports

Since 2009, 25 biosimilars of 12 originator products are approved in Japan and have yielded mixed performances and attained annual sales of ~¥32.4b ($300m). Unique biosimilars landscape with the entry of NESP “biosame” by originator Kyowa Hakko Kirin through its subsidiary, co-promotion/marketing collaboration with local companies for the...

  • Biopharmaceutical
  • Biosimilar
  • Japan
  • Biosimilar Penetration Rate
  • Biosimilar Approvals

Table ##: Retinitis Pigmentosa (Retinitis) – Pipeline by Staidson BioPharma Inc, H## 2020

  • Gene Therapy
  • Kyoto Prefecture
  • Drug Approval
  • Pharmaceutical Registrations

Sienna Biopharmaceuticals Inc

  • Arthritis
  • Pharmaceutical
  • Biopharmaceutical
  • World
  • Japan
  • Guangdong
  • Health Provider Density
  • Prescription Drug Sales

European Union Germany Therapy Monoclonal Antibody Biopharmaceutical Hospital

  • Pharmaceutical
  • Biopharmaceutical
  • Japan
  • Taiwan
  • South Korea
  • Drug Approval

Gene Therapy R&D and Revenue Forecasts 2020-2030: Retroviruses, Lentiviruses, Adenoviruses, Adeno Associated Virus, Herpes Simplex Virus, Poxvirus, Vaccinia Virus, Naked/Plasmid Vectors, Gene Gun, Electroporation, Lipofection, Cancer, Rare Diseases, Cardiovascular Disorders, Ophthalmologic Conditions, Infectious Disease, Neurological...

  • Gene Therapy
  • Japan
  • United States

A recent market study published by FMI – “Cell Line Development Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028” consists a comprehensive assessment of the most important market dynamics. On conducting a thorough research on the historic as well as current growth parameters of the Cell Line Development market,...

  • Cell Therapy
  • World
  • Japan
  • APAC
  • Health Expenditure

“Etanercept - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Cutaneous Lupus Erythematosus in 7 Major Markets. A detailed picture of the Etanercept in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan,...

  • Monoclonal Antibody
  • Europe
  • Japan
  • World
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • United States
  • Health Expenditure

Sienna Biopharmaceuticals Inc

  • Arthritis
  • Pharmaceutical
  • Biopharmaceutical
  • World
  • Japan
  • Prescription Drug Sales
  • Health Provider Density

Principia Biopharma Inc

  • Therapy
  • Colorectal Cancer
  • Pharmaceutical
  • Biopharmaceutical
  • Tobacco
  • World
  • Japan
  • Medicine Use
  • Cancer Mortality

CTI BioPharma Corp

  • Pharmaceutical
  • Biopharmaceutical
  • World
  • Japan
  • Indiana
  • Pharmaceutical Registrations
  • Stem Cell Transplantation

Asklepios BioPharmaceutical

  • Gene Therapy
  • World
  • China
  • Japan
  • European Union
  • Drug Approval
  • Prescription Drug Sales

INTRODUCTION Since the approval of the first therapy, Genedicine® in 2003, the gene therapy domain has evolved significantly. Specifically, in 2019, three gene therapies, namely Zolgensma® (US), Zynteglo™ (Europe) and Beperminogene Perplasmid (Japan), have received approval / conditional approval, leading to a marked upward...

  • Gene Therapy
  • World
  • United States
  • Europe
  • Japan
  • APAC
  • China
  • South Korea
  • Australia
  • Drug Approval
  • Number Of Enterprises

Report Scope The current report provides detailed exposure of media, sera and reagents used in cell culture.This report highlights the current and future market potential of culture media, sera and reagents used in cell culture along with a detailed analysis of the competitive environment, regulatory scenario, and technological...

  • Cell Therapy
  • World
  • Europe
  • North America
  • APAC
  • China
  • Japan
  • Middle East
  • United States
  • Mexico
  • United Kingdom
  • Canada
  • France
  • Germany
  • India

Oncolys BioPharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018

  • Biopharmaceutical
  • Pharmaceutical
  • Healthcare
  • Kyoto Prefecture

‘B-cell Non-Hodgkin’s Lymphoma—Market Insights, Epidemiology, and Market Forecast—2028’ report deliver an in-depth understanding of the disease, historical and forecasted epidemiology as well as the market trends of B-cell NHL in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. Geography...

  • Immunotherapy
  • Lymphoma
  • Spain
  • Germany
  • France
  • Japan
  • United States
  • Italy
  • United Kingdom
  • Stem Cell Transplantation

Monoclonal Antibody Biopharmaceutical

  • Biosimilar
  • India
  • United States
  • South Korea
  • Japan
  • Biosimilar Penetration Rate
  • Biosimilar Approvals

Principia Biopharma Inc

  • Pharmaceutical
  • Biopharmaceutical
  • Colorectal Cancer
  • World
  • Japan
  • Medicine Use
  • Cancer Mortality

Staidson BioPharma Inc

  • Monoclonal Antibody
  • Chronic Pain
  • Arthritis
  • Drug Development
  • Pharmaceutical
  • World
  • Japan
  • Pharmaceutical Registrations

Sep ##: AGC to Establish Mammalian cGMP-Compatible Contract Facility for Biopharmaceutical Development and Production at Chiba Plant

  • Biopharmaceutical
  • Pharmaceutical
  • Healthcare
  • Chiba Prefecture
  • Biologics Production

Seven and Eight Biopharmaceuticals

  • Gene Therapy
  • United States
  • Japan
  • Europe
  • Drug Approval
  • Medical Technology Density

Karnataka World India Biopharmaceutical Autoimmune Disease

  • Biosimilar
  • United States
  • India
  • Japan
  • South Korea
  • Biosimilar Penetration Rate
  • Biologics Penetration Rate

Major JP Innovator vs. Early entrant Mid size Japanese companies- TA focus approach – A Win Win Game! In this report, we attempt to evaluate key upcoming opportunity for Japan BS market, its competitive landscape, and current trend of biosimilars use in Japan. It also details Japanese “Chuikyo” (Central and Social Regulatory...

  • Biopharmaceutical
  • Biosimilar
  • Japan
  • Biosimilar Penetration Rate
  • Biosimilar Approvals

‘Adeno-Associated Virus (AAV) Vector Based Gene Therapy - Market Insights, Epidemiology and Market Forecast—2030’ report delivers an in-depth understanding of the AAV Vector Based Gene Therapy, historical and forecasted epidemiology as well as the AAV Vector Based Gene Therapy market trends in the United States, EU5 (Germany, France, Italy,...

  • Gene Therapy
  • United States
  • Germany
  • Spain
  • France
  • Japan
  • Italy
  • United Kingdom
  • Medical Technology Density
  • Hospital Admission

United States California North America Cell Therapy Regenerative Medicine Antidiabetics Therapy Diabetes Biopharmaceutical

  • Regenerative Medicine
  • Cell Therapy
  • United States
  • Japan
  • Europe
  • Drug Approval
  • Health Expenditure

Oncolys Biopharma Enters into Research Agreement with Osaka University

  • Pharmaceutical
  • Immunotherapy
  • Healthcare
  • Drug Delivery
  • Osaka Prefecture
  • Pharmaceutical Exports
  • Pharmaceutical Production

JSR Corporation, CMIC Holdings and INCJ to Acquire KBI Biopharma

  • Pharmaceutical
  • Drug Development
  • Healthcare
  • Regenerative Medicine
  • Japan
  • Health Insurance Claims
  • Manufacturing Orders

Summary Bristol-Myers Squibb Co (BMS) is a specialty biopharmaceutical company that carries out the discovery, development, licensing, manufacturing, marketing, distribution and sale of medicines to patients with serious diseases.Its primary focus is on cancer, cardiovascular, immunology and virology (including hepatitis...

  • Hepatitis
  • Biopharmaceutical
  • Pharmaceutical
  • HIV AIDS
  • Pharmacy
  • Europe
  • APAC
  • New York
  • North America
  • Japan
  • Middle East
  • United States
  • Africa
  • World
  • Prescription Drug Sales

Biopharmaceutical

  • Ovarian Cancer
  • Gene Therapy
  • United States
  • World
  • Australia
  • Japan
  • Europe
  • Drug Approval
  • Food Production

Over the past several years, the biopharmaceutical industry has witnessed an increasing number of contract suppliers taking on the CDMO (contract development and manufacturing organization) acronym to identify their ability to assist at the development stage of drug manufacturing.

  • Cell Therapy
  • Japan
  • Drug Approval
  • Out Of Pocket Expenditure

## Apceth Biopharma GmbH PIPELINE, H## 2018

  • Therapy
  • Cell Therapy
  • Japan
  • Mortality Rate
  • Drug Approval